PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.02%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
5.99%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
44.10%
Positive EBIT growth while TSM is negative. John Neff might see a substantial edge in operational management.
44.10%
Positive operating income growth while TSM is negative. John Neff might view this as a competitive edge in operations.
29.80%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
25.00%
EPS growth above 1.5x TSM's 5.32%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
23.08%
Diluted EPS growth above 1.5x TSM's 5.32%. David Dodd would see if there's a robust moat protecting these shareholder gains.
2.33%
Slight or no buybacks while TSM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.77%
Slight or no buyback while TSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
62.89%
OCF growth of 62.89% while TSM is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
770.89%
FCF growth of 770.89% while TSM is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
162.62%
Similar 10Y revenue/share CAGR to TSM's 162.19%. Walter Schloss might see both firms benefiting from the same long-term demand.
162.62%
5Y revenue/share CAGR similar to TSM's 162.19%. Walter Schloss might see both companies benefiting from the same mid-term trends.
162.62%
3Y revenue/share CAGR above 1.5x TSM's 64.05%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
1486.11%
OCF/share CAGR of 1486.11% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
1486.11%
OCF/share CAGR of 1486.11% while TSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
1486.11%
3Y OCF/share CAGR of 1486.11% while TSM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
294.43%
Positive 10Y CAGR while TSM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
294.43%
Positive 5Y CAGR while TSM is negative. John Neff might view this as a strong mid-term relative advantage.
294.43%
Positive short-term CAGR while TSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
403.32%
Equity/share CAGR of 403.32% while TSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
403.32%
Equity/share CAGR of 403.32% while TSM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
403.32%
Equity/share CAGR of 403.32% while TSM is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.26%
AR growth of 30.26% while TSM is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
3.27%
Inventory growth of 3.27% while TSM is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
9.93%
Asset growth of 9.93% while TSM is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
11.28%
BV/share growth of 11.28% while TSM is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
1.65%
Debt growth of 1.65% while TSM is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
8.31%
R&D growth of 8.31% while TSM is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
5.48%
SG&A growth of 5.48% while TSM is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.